Gastroenterology News

OpenBiome will continue distribution of investigational fecal microbiota transplantation through 2024, as suspension may put certain patients with recurrent, refractory or fulminant Clostridioides difficile at risk, according to the AGA.

PHILADELPHIA — Paul Kwo, MD, professor of medicine at Stanford University, speaks with Healio about presentations investigating the undertreatment of hepatitis B.

PHILADELPHIA — In this video, Paul Kwo, MD, professor of medicine at Stanford University, discusses a plenary session about the “emerging role” of mycophenolate mofetil for the treatment of autoimmune hepatitis.

BOSTON — Fewer patients hospitalized for acute pulmonary embolism with pancreatic cancer died in 2020 compared with rates in 2001, according to a presentation at the CHEST Annual Meeting.

PHILADELPHIA — Glucagon-like peptide-1 receptor agonist use was associated with prolonged gastric transit time and incomplete small bowel evaluation among patients with diabetes undergoing video capsule endoscopy, according to research.

PHILADELPHIA — Iqirvo demonstrated significant biochemical response and alkaline phosphatase normalization in patients with both early- and advanced-stage primary biliary cholangitis, according to late-breaking data presented here.

The four core concepts of the CDC’s Social Vulnerability Index could be used to predict the severity of Clostrioides difficile infection and all-cause mortality, according to a study presented at IDWeek.

As a physician, your career will be rewarding in many ways, including a personal sense of purpose, ability to help others and the potential for high-earning power.

PHILADELPHIA — Patients with a false-positive Shield test result did not appear to be at increased risk for non-colorectal cancer malignancies at 1 year compared with those with a true-negative result, according to a presenter here.

PHILADELPHIA — The AIMS65 risk score may help predict which patients with direct oral anticoagulant-associated gastrointestinal bleeding are at heightened risk for rebleeding and death, according to late-breaking data.